W
hen researchers realized a decade ago that genes inhabit a specific space within a cell's nucleus and that they sometimes change location during differentiation and in certain diseases, they began to contemplate why.
Tom Misteli, Ph.D., and his group at the National Cancer Institute are now asking whether they can exploit evidence of gene movement as a diagnostic tool.
In a preliminary study comparing 14 invasive breast cancer tissue samples with 11 healthy breast tissue samples, the researchers found that several genes have a different physical position in the nucleus in invasive breast cancer. One gene, HES5, known to affect pathways involved in cancer, allowed identification of invasive breast cancer in more than 90% of cases. The fi ndings were published in the December 14, 2009, Journal of Cell Biology .
Today pathologists look through a microscope in search of distinctive changes in shape and size of the cell nucleus as signs of cancer. But the Misteli group's approach is different because it's quantitative and spatial. They use fl uorescence in situ hybridization to label specifi c genes in an intact nucleus. Using little tissue, just 100 -200 cells, they can compare gene position in biopsy tissue against a standardized normal.
"To the best of my knowledge, we are the only group trying to utilize the position of genes for diagnostic purposes," said Karen "What's so exciting about Karen's paper is it's a large number of genes and she did it in tumor biopsies," says Joanna M. Bridger, Ph.D., deputy director of the Centre for Cell and Chromosome Biology at Brunel University in West London. "The data are so nice that she can make that correlation with diagnosis." Meaburn did her doctoral studies in Bridger's lab.
Location, Location, Location
Thomas Cremer, M.D. , is convinced that nuclear architecture is critical to understanding gene expression. Cremer, chair of anthropology and human genetics at Ludwig Maximilians University in Munich, Germany, was one of the fi rst to fi nd evidence in the 1980s that the nucleus is not a spaghetti-like mass of crowded chromatin fi bers. Instead, the genetic material in the nucleus is highly organized and inhabits specifi c territories.
Later, it became clear that some chromosomes exist toward the periphery of the nucleus and others are located toward the center.
"We wanted to understand how the nucleus is organized, and we found there is not only architecture, but it's much more complex and dynamic. And it's obviously functionally important," said Cremer.
"You need genes to be in the right place," agreed Bridger. Some genes will stay where they are, others move out in big loops toward the nuclear interior. In mammalian cells, the interior is where more transcription factories are, she said. But movement to the center for gene expression and to the periphery for silencing isn't a cast-iron rule. There are genes expressed at the nuclear periphery and others silenced in the interior. But in recent experiments, researchers manipulated the location of chromosomes and saw an effect on gene expression.
Across several species, patterns of chromosome arrangement are specifi c to both cell type and tissue type. In human lymphocytes, the gene-dense chromosome 19 is located in the interior of the nucleus, whereas chromosome 18, which has few genes, is at the periphery. In primates and gibbons, the genes from chromosome 19 are distributed in four segments on other chromosomes, but Cremer's group found that their spatial organization is just the same as in the human cell nucleus. In chickens, those same genes are in microchromosomes but are still positioned in the interior of the cell, and those genes relative to chromosome 18 are in jnci.oxfordjournals.org JNCI | News 297 N E W S the periphery. "Despite dramatically different karyotypes, there seem to be spatial rules on how chromatin is arranged," Cremer said.
Genes are more likely to be near each other if they work together, according to Groudine, who found location changes during differentiation of blood cells. These genes may share specifi c transcription factors. Groudine is studying fundamental aspects of what determines which chromosomes are near each other and where genes are located in a given nucleus. "Obviously, it would be very interesting to see if we can fi gure out a mechanism for why these genes are moving," he said. "Maybe they are associating with different transcription factors and cancer cells make them colocalize for access."
Cremer wants to understand more about how this all works before moving toward diagnostics. "The nuclear architecture is something you need to understand," he said. "We'll then see more how it fi ts to certain diagnostic questions."
Time for Validation
In Bridger's UK lab, Meaburn studied chromosome territory behavior in disease, focusing on cells derived from patients with the premature aging disease Hutchinson -Gilford progeria syndrome. This disease is caused by a mutation in the lamin A gene, which may generate problems in the connection between chromatin and the nuclear lamina. She and her colleagues found chromosomes in the wrong location in the nucleus, which could affect expression of certain genes in these patients ' cells. Bridger's group is still investigating the consequence of chromosome or gene mislocalization in these cells. At NCI, Meaburn fi rst used a 3-dimensional breast cell culture model to look for gene movement during cancer progression. Several genes moved within 10 days after cancer activation. "That's an early event," said Meaburn. "And we know that genes change position before they change expression." So they analyzed tumor samples and normal tissue, asking, "Can we come in with an unknown sample to say, 'Yes or no, it's cancer based purely on gene movement ' ?"
In this most recent study of invasive breast cancer samples and normal tissue, eight genes stood out. Seven genes (TGFB3, AKT1, ERBB2, CSF1R, HSP90AA1, FOSL2, and MYC) were repositioned in 53% -71% of comparisons. One gene, HES5, was repositioned in 91% of comparisons. Several combinations of two or three genes allowed identifi cation of cancerous tissues with low false-negative and false-positive rates.
"The movement of HES5 was fairly bigit moved half the radius of the nucleus, on average," Meaburn said. "Others were fairly small, but we could pick them up as statistically signifi cant."
Because movement occurred early in the 3-D cell culture model, the researchers are hopeful that they can use their system as an early indicator of breast cancer. "I see it as one more readout, to be added to existing tests," Meaburn said. The researchers are now looking at more samples to validate the results and are working to automate the process so they can analyze hundreds of samples quickly.
They are interested in other cancers as well. Using samples sent by Lawrence W. True, M.D., a professor of pathology at the University of Washington Medical Center in Seattle, they have begun to look for gene position changes in prostate cancer. True said that the plan is to look at several hundred samples.
A key question is whether they will fi nd movement in the same genes as seen in breast cancer or different ones. There are global similarities between the two: Both have hormonal sensitivity and evolve over multiple years. "Since they have the probes for the breast cancer genes, it's quite reasonable to start with those," True said.
True is hoping that this line of research can begin to explain why pathologists can see such extreme differences in nuclei of cancer cells versus normal cells. Right now, there is no substantial molecular or mechanistic basis for understanding why their appearance is so different microscopically. With these studies, he said, "we can begin to probe into mechanisms that lead to differential positioning of genes to sites where they can be actively transcribed."
The fi eld of researchers working to understand why and how these genes are moving is growing. "You can't ignore it," said Cremer, who pointed to an upcoming June meeting at Cold Spring Harbor Laboratory on nuclear organization and function. "But we have a long way to go before this method is really useful for giving patients information for decision making and not just for scientists who are interested."
